Mydecine Reports Financial Results for the Year Ended

DENVER, March 31, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology...

Related Keywords

Denver ,Colorado ,United States ,Netherlands ,Canada ,London ,City Of ,United Kingdom ,Canadian ,Joshua Bartch ,Matt Johnson Al Garcia Romeu ,Canadian Stock Exchange ,Johns Hopkins University ,Mindleap Health Inc ,Imperial College Of London ,Johns Hopkins University School Of Medicine ,Macquarie University ,Youtube ,Twitter ,Mydecine Innovations Group Inc ,Pangenomic Health Inc ,Leiden University Medical Center ,World Intellectual Property Organization ,Mydecine Innovations Group ,European Union ,University Of Alberta ,Instagram ,Linkedin ,Innovations Group ,Mindleap Health ,Pangenomic Health ,World Intellectual Property ,Common Share Subscription Agreement ,Common Share ,Johns Hopkins University School ,Imperial College ,Matt Johnson ,Novel Psilocin Analog Compositions And Methods ,Synthesizing The ,Novel Functional Fungal Compound Formulations ,Their Therapeutic Methods Of Use ,Year Ended December ,Chief Executive Officer ,Aequitas Neo Exchange Myco Ne ,